Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Interest & Investment Income (2016 - 2019)

Historic Interest & Investment Income for Dexcom (DXCM) over the last 7 years, with Q1 2019 value amounting to $6.9 million.

  • Dexcom's Interest & Investment Income rose 6829.27% to $6.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $7.8 million, marking a year-over-year decrease of 2641.51%. This contributed to the annual value of $2.4 million for FY2018, which is 6417.91% down from last year.
  • According to the latest figures from Q1 2019, Dexcom's Interest & Investment Income is $6.9 million, which was up 6829.27% from -$3.8 million recorded in Q4 2018.
  • Over the past 5 years, Dexcom's Interest & Investment Income peaked at $6.9 million during Q1 2019, and registered a low of -$3.8 million during Q4 2018.
  • Its 4-year average for Interest & Investment Income is $1.4 million, with a median of $500000.0 in 2017.
  • Within the past 5 years, the most significant YoY rise in Dexcom's Interest & Investment Income was 195000.0% (2018), while the steepest drop was 17916.67% (2018).
  • Over the past 4 years, Dexcom's Interest & Investment Income (Quarter) stood at -$600000.0 in 2016, then skyrocketed by 900.0% to $4.8 million in 2017, then plummeted by 179.17% to -$3.8 million in 2018, then soared by 281.58% to $6.9 million in 2019.
  • Its last three reported values are $6.9 million in Q1 2019, -$3.8 million for Q4 2018, and $2.5 million during Q3 2018.